• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Blue Jet Healthcare Ltd
    30 Apr 2025
    663.35
    0.26%
    Broker's call: Blue Jet Healthcare (Buy)
    Business Line
    The company has established itself as a reliable supplier to its customers for the past three decades and is now working toward moving up the value chain by significantly increasing its investment in RD
    Copy LinkShare onShare on Share on Share on
    Blue Jet Healthcare Ltd has lost -26.07% in the last 3 Months
    Blue Jet Healthcare jumps 6% as MOFSL initiates coverage, 26% upside seen
    Business Standard | 30 Apr 2025 1 more
    Blue Jet Healthcare Gets 'Buy' As Motilal Oswal Initiates Coverage, Sees 26% Upside
    NDTV Profit | 30 Apr 2025
    logo
    AstraZeneca Pharma India Ltd.
    29 Apr 2025
    9331.00
    1.18%
    AstraZeneca says potential US tariffs manageable; faces another China fine
    Business Standard
    "If tariffs were implemented in the range we have seen recently in other industries on medicines imported from Europe to the U.S., we would remain within the guidance range we indicated for 2025,"
    Copy LinkShare onShare on Share on Share on
    AstraZeneca Pharma India Ltd. is trading above all available SMAs
    logo
    Pfizer Ltd.
    29 Apr 2025
    5222.50
    1.39%
    Pfizer beats Q1 profit estimates on cost cut, strong sale of heart drug
    Business Standard
    It reported total revenue of $13.70 billion for the first quarter, compared with analysts' expectations of $13.91 billion, according to LSEG data
    Copy LinkShare onShare on Share on Share on
    Pfizer Ltd. is trading above its 200 day SMA of 4889.0
    logo
    Aurobindo Pharma Ltd.
    29 Apr 2025
    1093.30
    0.67%
    Fire Incident halts production at Aurobindo Pharma subsidiary
    Business Line
    As a precautionary measure, operations at the plant will be suspended for an estimated 20 to 25 days while equipment is replaced
    Copy LinkShare onShare on Share on Share on
    Aurobindo Pharma Ltd. has an average target of 1403.50 from 10 brokers.
    logo
    Morepen Laboratories Ltd.
    29 Apr 2025
    49.23
    0.86%
    Morepen gets regulatory clearance for fatty liver drug development
    Business Line
    The shares of Morepen Laboratories Limited were trading at 62.36 up by 0.31 or 0.50 per cent on the NSE at 10 am
    Copy LinkShare onShare on Share on Share on
    Morepen Laboratories Ltd. has lost -41.68% in the last 1 Year
    logo
    Natco Pharma Ltd.
    29 Apr 2025
    822.55
    1.98%
    Stock to buy today: Natco Pharma (883.95)
    Business Line
    The upswing that followed has taken the stock above a notable resistance at 840 and both 20- and 50-day moving averages, turning the short-term outlook bullish
    Copy LinkShare onShare on Share on Share on
    Geojit BNP Paribas decreased Hold price target of Natco Pharma Ltd. to 940.0 on 17 Sep, 2025.
    logo
    Natco Pharma Ltd.
    29 Apr 2025
    822.55
    1.98%
    Today's Stock Recommendation: April 29, 2025
    Business Line
    Will NATCO Pharma's stock trend this week?
    Copy LinkShare onShare on Share on Share on
    Natco Pharma Ltd. has lost -39.25% in the last 1 Year
    logo
    RPG Life Sciences Ltd.
    28 Apr 2025
    2269.70
    0.22%
    RPG Life Sciences Q4 Results: Profit Surges 786% On One-Time Gain
    RPG Life Sciences Q4 Results: Profit Surges 786% On One-Time Gain
    NDTV Profit
    The company also recommended a final dividend of Rs 20 per share.
    Copy LinkShare onShare on Share on Share on
    RPG Life Sciences Ltd. is trading below all available SMAs
    logo
    Dr. Reddy's Laboratories Ltd.
    28 Apr 2025
    1248.10
    0.27%
    Dr Reddy's Laboratories, Sanofi Healthcare partner for respiratory drug
    Business Standard
    Under the agreement, Dr Reddy's will have exclusive rights from SHIPL to promote and distribute Beyfortus within the country
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laboratories Ltd. is trading above its 200 day SMA of 1243.8
    Dr Reddy's To Introduce Sanofi's Novel RSV Drug Beyfortus In India
    NDTV Profit | 28 Apr 2025
    logo
    Cipla Ltd.
    27 Apr 2025
    1517.70
    0.31%
    Cipla open to expanding manufacturing footprint to strengthen US presence
    Business Standard
    The US already contributes a significant share, around a quarter, of Cipla's total revenues
    Copy LinkShare onShare on Share on Share on
    Cipla Ltd. has an average target of 1702.60 from 10 brokers.
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • DSM Fresh Foods
    • Greenleaf Envirotech
    • NSB BPO Solutions
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd (RA SEBI Reg No: INH000022507)